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Abstract
Background: Hepatitis C virus (HCV) is mainly transmitted by exposure to infected blood, and can lead to liver cirrhosis
and liver cancer. Since the onset of HCV and the development of liver cirrhosis usually are asymptomatic, many HCV-
infected individuals are still undiagnosed. To identify individuals infected with HCV in the general population, a low
threshold, internet-mediated blood testing service was set up. We performed a qualitative study examining reasons for
compliance and noncompliance with advice to test for HCV via the online blood testing service.
Methods: Semistructured telephone interviews were conducted with 33 website visitors who had been advised to
test for HCV (18 testers, 15 non-testers). Transcribed interviews were analyzed qualitatively and interpreted using
psychosocial theories of health behavior.
Results: Reasons for testing pertaining to the online service were: the testing procedure is autonomous, personalized
test advice is provided online, reminder emails are sent, and there is an online planning tool. Reasons for testing not
specific to the online service were: knowing one’s status can prevent liver disease and further transmission of HCV, HCV
is curable, testing can provide reassurance, physical complaints are present, and there is liver disease in one’s social
environment. Service-related reasons for not testing pertained to inconvenient testing facilities, a lack of commitment
due to the low threshold character of the service, computer/printing problems, and incorrectly interpreting an online
planning tool. The reasons for not testing that are not specific to the online service were: the belief that personal risk is
low, the absence of symptoms, low perceived urgency for testing and treatment, fear of the consequences of a positive
test result, avoiding threatening information, and a discouraging social environment.
Conclusions: Features specific to the online service played a significant role in motivation to test for HCV above
and beyond the more conventional perceived health benefits of HCV testing. However, some online specific
features were considered problematic and need to be adapted. Methods and strategies for dealing with these
impeding factors and for improving compliance with testing via the online service are outlined.
Background
Hepatitis C virus (HCV) infection, caused by a blood-
borne virus and first identified in 1989, is a major public
health problem. Worldwide an estimated 123 million
individuals are HCV antibody positive, [1] approximately
75% of whom are chronically infected and at risk for the
development of cirrhosis, liver cancer, and death [2,3].
In chronically infected patients, the onset of HCV itself
and the development of cirrhosis are usually asympto-
matic [2,4]. Therefore, many infections remain unde-
tected or are diagnosed late. On the basis of
mathematical modeling, the HCV-related morbidity and
mortality rates in high-income countries are expected to
at least double in the next 2 decades [5,6]. Because suc-
cessful combination therapy for HCV became widely
available in 2001 [7-11] and an era of new therapeutic
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any medium, provided the original work is properly cited.options is expected shortly [12,13], the challenge now is
to identify as many HCV-infected individuals as possi-
ble. Consequently, the Public Health Services of Amster-
dam and South Limburg introduced the Hepatitis C
Internet Project, a pilot study aimed at identifying
undiagnosed HCV-infected individuals in the general
population.
In the Netherlands, the estimated HCV prevalence is
low (0.1-0.4% [14]). Therefore, the strategy used in the
Hepatitis C Internet Project consisted of a public media
campaign that addressed HCV risk factors and referred
risk groups to an online HCV risk assessment question-
naire at http://www.heptest.nl[15]. Individuals who vis-
i t e dt h ew e b s i t ea n dw e r ei d e n t i f i e db yt h e
questionnaire as at risk were advised to get tested for
HCV and were immediately offered the opportunity to
arrange, online, a free and anonymous HCV blood test.
The website also provided information about HCV risks
that was tailored to the individual’sr i s kp r o f i l ea n d
emphasized the severity of HCV infection, its often
asymptomatic onset, and the benefits of treatment. It
also explained the testing procedures, stating that the
blood test procedure includeda ni n i t i a lH C Va n t i b o d y
t e s t ,af o l l o w - u pt e s tf o rt h ose who tested positive, and
a direct referral to the hospital for those infected with
HCV. Individuals could arrange the blood test them-
selves by printing out a laboratory form that contained a
personal identification code with which participants
could anonymously obtain their test result online seven
days after testing. The form also included addresses and
opening hours of the participating low threshold test
locations. In order to increase the test uptake, indivi-
duals were offered an online planning tool for testing
where they could specify the date, time, and location
upon which they would have their blood drawn for the
HCV test. The tool explicitly mentioned that it did not
result in an actual appointment with the laboratory and
that individuals later could decide to take their test at a
different date, time, or location. The tool was considered
advantageous because, according to the theory of Imple-
mentation Intentions [16], detailed planning of when
and how to execute an intended action facilitates the
actual performance of the behavior. In addition, indivi-
duals could subscribe to an email and/or a mobile
phone Short Message Service (SMS) reminder system if
they wanted to receive a reminder message for blood
testing five days after they completed the risk assess-
ment questionnaire.
While 28% (n = 420) of the individuals who completed
the risk assessment questionnaire and were found to be
at risk for HCV infection (n = 1,480) complied with the
test advice and were tested for HCV, a substantial pro-
portion (72%) failed to visit the test locations. Because
the online testing service is new, it is unclear which
service-related factors promoted or impeded website
visitors’ decision to test for HCV. Understanding why
some complied with the advice to test through the
online service and others did not is vital to not only the
further implementation of this service but also to the
improvement of HCV testing campaigns in general.
Therefore, this study investigated reasons for compli-
ance and noncompliance with the HCV test advice
obtained through the online risk screening tool and
focused particularly on the role of the online blood test-
ing procedures in that process. A descriptive qualitative
design was used to be able to explore and understand
the participants’ views and motives with regard to HCV
testing.
Theoretical background
The health belief model [17,18], the theory of planned
behavior [19], and the extended parallel process model
[20] were used as theoretical bases for the interpretation
of the findings. The health belief model focuses on per-
ceived severity of and vulnerability to a disease (per-
ceived threat), perceived barriers to and benefits of
executing the behavior (expectations regarding the out-
comes of the positive health behavior), perceived self
efficacy (the degree to which one perceives oneself cap-
able of executing the health behavior), and cues to
action (stimuli which trigger the cognitive processes that
lead to the health behavior). Applied to the context of
HCV screening, the likelihood of HCV testing increases
when perceived threat of HCV is high, perceived bar-
riers of testing are low, perceived benefits of testing are
high, self efficacy for testing is high, and relevant cues
for action are present.
The theory of planned behavior suggests that behavior
is determined by more than just health beliefs. Accord-
ing to the theory of planned behavior, attitudes (perso-
nal evaluations of the behavior based on behavioral
beliefs), subjective norms (perceptions of other people’s
evaluations of the behavior based on normative beliefs),
and behavioral control (perceived control over the
execution of the behavior based on control beliefs; simi-
lar to self-efficacy) determine the intention to engage in
a behavior. Behavioral intention is presumed to best pre-
dict behavior. However, actual behavioral control (e.g.
lack of control due to environmental factors) can also
directly influence behavior. Applied to the context of
HCV screening, the likelihood of HCV testing increases
when attitudes towards testing are positive, when sub-
jective norms favor HCV testing, and when perceived
behavioral control is high.
The extended parallel process model also focuses on
health beliefs but is more specific than the health belief
model with regard to the role of emotion in responses
to a perceived health threat. According to the extended
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duals to engage in either danger control or fear control
processes. Danger control is aimed at reducing the
health threat through cognitively processed adaptive
responses (e.g. seeking testing and treatment), whereas
fear control is aimed at reducing unpleasant feeling
related to the health threat. Fear control often results in
maladaptive responses such as message avoidance and
defensive reactions (e.g. denial of risk). Whether indivi-
duals engage in danger or fear control processes
depends on the degree to which threat, self efficacy, and
response efficacy (the extent to which the recommended
behavior is expected to effectively reduce the threat) are
perceived to be present [20]. Medium to high perceived
threat combined with high perceived efficacy will most
likely result in danger control responses while high per-
ceived threat combined with low perceived efficacy will
most likely lead to fear control responses. In a study
conducted with men who have sex with men (MSM) by
Mikolajczak et al. [21], men at risk for HIV mentioned
b o t ht h ef e a ro ft e s t i n gH I V - p o s i t i v ea n dal o wp e r -
ceived risk of HIV infection as reasons for not testing,
thus implying that cognitive dissonance reduction takes
place. Applied to the context of HCV screening, the
extended parallel process model would suggest that the
likelihood of HCV testing is greatest when individuals
perceive the threat of HCV as moderate to high and
possess high levels of perceived self efficacy and
response efficacy.
Methods
Recruitment and Sample
Because the Hepatitis C Internet Project was anon-
ymous, only individuals who had subscribed to the
reminder service could be contacted for participation in
this study. To note, those who subscribed to the service
were informed that they could receive an email invita-
tion for participation in a study. Recruitment took place
among these individuals between May and July 2007
and between May and July 2008 (n = 97). The invitation
sent by email briefly explained the study procedures and
indicated that the aim of the study was to improve the
project by hearing the opinions of participants. The invi-
tation was sent at least three weeks after the potential
participant’s website visit, in order to provide the parti-
cipant with sufficient time to be tested, but no later
than three months, in order to reduce potential recall
bias. If individuals did not reply to the email invitation
within two weeks, an email reminder was sent. Recruit-
ment of participants continued until data saturation [22]
was reached, i.e. until no new reasons for compliance or
noncompliance emerged from three consecutive inter-
views. In total, 33 interviews were conducted. Informa-
tion regarding demographics (sex, level of education,
and country of birth) and HCV risk factors were
obtained from the online risk assessment questionnaire
data. Age was asked during the interview.
Procedure
Semistructured interviews were chosen as they allow
flexibility, facilitate empathy, enable the interview to
explore new topics, and tend to produce rich data [23].
Interviews were conducted in Dutch by telephone. Tele-
phone interviews were considered the most ideal choice
as they lower possible barriers to participation (e.g. tra-
velling to the Public Health Service) and enhance anon-
ymity. Two female researchers conducted interviews of
approximately 15 minutes each. Every interview com-
menced by explaining the purpose of the interview fol-
lowed by an oral informed consent. The following topics
were then addressed: motives for visiting http://www.
heptest.nl and filling out the risk assessment question-
naire; feelings about the outcome of the risk assessment;
personal perception of risk for HCV infection (this topic
was added after the first two interviews); and the rea-
sons for compliance or noncompliance with the advice
to test for HCV. The central topic of the interview con-
cerned why participants used or did not use the pro-
ject’s testing service. Follow-up probes (e.g., “Could you
explain this further?”) were applied to motivate partici-
pants to provide a detailed rationale for their test deci-
sion. All interviews were audio-taped and transcribed
verbatim (quotes are translated). Participants were pro-
vided with a gift certificate as reward for their
participation.
Analyses
The transcribed interviews were entered into a database
for coding and content analysis using qualitative data
analysis software (MAXqda 2007). The data analysis
team consisted of four researchers from different disci-
plines (communication science, biomedical science, psy-
chology, and anthropology). The data analysis consisted
of two phases; in the first phase the data were analysed
in an inductive manner, not informed by the theoretical
frameworks. In the second phase, the results of the first
phase were interpreted using the theoretical frameworks.
A detailed description of the two phases follows below.
Phase 1: After conducting the first two interviews, two
researchers independently coded those interviews. In
order to stay as close as possible to the phenomenon
described by the participants, coding was inductive and
open, not yet classified or interpreted through the theo-
retical frameworks, and an unrestricted number of facets
were expressed in preliminary code names. A discussion
meeting with the data analysis team then took place to
ensure that all relevant content was incorporated in
codes. Furthermore, based on the first two interviews,
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the initial interview schedule. Thereafter, two additional
interviews were conducted and discussed. This iterative
process of interviewing alternated with open coding and
a team discussion comprised three rounds. Thereafter,
when all 33 transcripts were coded, the team reached
consensus on the final code names. The codes had to be
concise and self-explaining. If multiple codes were
found that refer to a similar principle (e.g., the codes:
‘inconvenient opening hours of the laboratories’, ‘no
evening opening hours’,a n d‘needing an appointment
for a specific time to be tested at the closest laboratory’),
codes were merged together (in this example into
‘inconvenient test facilities’), reducing the number of
codes. Consequently, the first author then reread the
coded segments of the 33 transcripts to confirm that all
coded segments fitted in the final code names.
Phase 2: Focusing on the research question, the team
then grouped the relevant codes into categories based
on the theoretical background of the health belief
model, the theory of planned behavior, and the extended
parallel process model. Each category was based on at
least one code.
Ethical framework
Prior to the interviews, participants were informed
about the purpose of the interview and the fact that
they could withdraw from participation whenever they
wished (also after finishing the interview), by emailing
the researcher that had contacted them via email pre-
viously (none of the participants withdrew). Oral
informed consent for audio taping the interview was
requested before the interview started. To maximize
confidentiality, potential personal identifiers were
deleted from the transcripts, and only the involved
researchers had access to the interview transcripts. The
study was approved by the Ethical Committee Psychol-
ogy of the School of Psychology and Neuroscience,
Maastricht University.
Results
Sample characteristics
Most participants (91%; 30/33) were born in the Nether-
lands and female (79%; 26/33). Median age at the time
of the interview was 49 years (IQR = 41-62 years). Edu-
cational level varied from low (22%) to moderate (19%)
to high (59%). Of the 33 participants, 18 (55%) had
complied with the test advice and had used the project’s
testing service. One of these 18 had tested positive for
HCV. The participants belonged to various HCV risk
groups. The most frequently reported risk was having
had a blood transfusion before 1992 (n = 16), followed
by having the skin pierced in countries with medium to
high HCV prevalence (n = 13). Other reported risks
were former injecting drug use (n =2 ) ,f r e q u e n tu s eo f
non-injection illicit drugs (i.e., cocaine, heroine, amphe-
tamine, LSD, GHB and/or poppers; n = 1) and living
together and sharing bathroom attributes with HCV
positive individuals or drug users (n =4 ) .T h r e ep a r t i c i -
pants had multiple HCV risks.
Reasons for testing related to the online testing
procedures
From the interviews with participants that had been com-
pliant with the advice to test (N = 18), we identified five
reasons for testing that related directly to the online test-
ing procedure (see upper right section of Figure 1). The
first reason was that the online testing service allowed
individuals access to a test without having to discuss or
explain their desire to be tested for HCV with their gen-
eral practitioner (GP). This reason was labeled ‘to avoid
the GP’ and is illustrated by the following quotes:
“At that time [years ago], I thought about testing but
Id i d n ’t do it. [...] The reason is that, back then, you
had to visit the GP - it was the standard procedure -
and you’d have to tell him or her why you want a
test [...] and, with this offer, you can remain anon-
ymous but still get tested.” (tester [T]-8)
“I have a lot of health problems. Visits to the GP are
time-consuming and, above all, you don’t want to be
thought of as a whiner. [...] Everytime you have
something, you kind of start to dislike to yourself
and, by bringing it up with the GP, it’sl i k ey o ua r e
again make a big deal out of things.” (T-9)
The second reason for compliance pertaining to the
testing service was that the online service enabled users
to become well-informed about HCV and the testing
procedures without time pressure and at their own pace.
The fact that participants ‘could obtain information
independently’ enabled them to deliberate about whether
or not they should test for HCV:
“Well, after doing the risk test and being told that I
need to test, then you can search for information your-
self and find out what it all means, you know? Then
you are not blindly having your blood drawn while you
actually know nothing. You can immediately search on
the internet. You can look up why or how and what...
Then I think, ‘It’s not so scary, I’ll do it’” (T-1).
The third reason was that there was ‘personalized test
advice’. The tailored feedback on risk factors provided
motivation to test, as illustrated by the following quote:
“Well it [the personal advice] is so clear that you feel
compelled to follow the advice you receive” (T-8).
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reminded to get tested. ‘Receiving a reminder e-mail/
sms message’ alerted individuals to the test advice and
promoted testing, as illustrated by the following the
quote:
“Well, actually, I think if I didn’t get that reminder
of yours, it would have ended up in the back of my
mind, like something I would have to do some time.
[...] Without the reminder, I probably wouldn’th a v e
gotten tested.” (T-12)
The final reason for compliance related to the online
service was the availability of the online planning tool.
The ‘use of the online planning tool’ stimulated partici-
pants to test:
“It h i n ki t ’s a helpful tool. They ask you what date
you want to go. I thought, ‘Hey, that’sg o o d .I ’ll just
pick that date. I’ll do it. I’l lj u s tp u ti ti nm yd a y -
planner and I’ll do it’” (T-7).
Reasons for testing unrelated to the online testing service
We identified ten reasons for testing that were unrelated
to the online testing service (see upper left section of
Figure 1). First, participants mentioned health gain from
early detection of HCV. This was labeled as ‘preventing
liver disease’ and is illustrated by the following quote:
“These diseases always start small. They are invisible
and, later on, they develop further and, at a certain
point, you’re too late for treatment. You know, it
gives you problems. If you find it at an early stage,
you may be able to cure or treat it.” (T-4)
Secondly, participants reported testing because the
undetected virus could spread to other people. This rea-
son was labeled as ‘preventing further transmission’ and
is illustrated by the following quote:
“I thought, ‘Well, for goodness’ sake, let me get the
test.’ [...] also because I could infect others with it”
(T-7).
Figure 1 Reasons for compliance (+) and noncompliance (-) with online advice to test for HCV. The left section of the figure presents the
reasons related to HCV testing in general whereas the right section presents reasons specific to testing via the online blood testing service.
Note. HCV = hepatitis C virus
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HCV’. This reason focused on the fact that there are
treatment options for HCV when diagnosed. One parti-
cipant said,
“I also read that there are medications and stuff
available, so I thought ooohkay. [...] I thought, ‘Well,
this is not very scary, I will do it.’ You get me?” (T-
1).
Another participant stated, “I heard that if you have
it, it can be effectively treated, at least if you’ve
detected it at an early stage. That’s why I reacted
immediately” (T-6).
Furthermore, some participants expressed that caring
for one’s own health and body was imperative. ‘Taking
responsibility for one’sh e a l t h ’ was thus one of the rea-
sons to test for HCV:
“Look, when I hear about something like this, I take
action immediately. It is my body and I believe that
we should care for our bodies. And when you are
offered something like this, well, then you should do
it” (T-18).
Some participants mentioned that they got tested
because they wanted to know their HCV status. They
were not scared of the test results but reported that
they were ‘seeking reassurance’:
“Iw a s n ’t afraid that something was wrong but, yes, I
wanted to be sure.” (T-5); and “I have other things, I
mean unpleasant things [medical conditions] so I
liked being able to exclude something” (T-9).
Several participants had incorrect perceptions regard-
ing HCV risks. They had experienced certain events that
they considered to pose a risk. Although these events
posed no actual risk, they did increase perceived risk
and motivated individuals to test. We labeled this reason
as ‘imaginary risks’:
“I’ve had numerous medical examinations and much
more. I’ve had a stroke, three TIAs. [...] I used to go
for walk in wooded areas and I’ve been bitten by
ticks [...] so I thought, “Oh, oh maybe it [being HCV
positive] could be because of all that.” (T-2)
Also, some participants reported testing because they
were ‘experiencing general physical complaints’.O n e
participant said the following:
“It said that you could be carrier for a long time and
that it won’t manifest itself - only maybe in a much
later stage - that it can take years. And yes, well
maybe it’s because lately I have had a lot of com-
plaints that I never had before. I thought well, ‘For
goodness’ sake, let me get the test.’” (T-7)
In addition, knowing people with liver-related diseases
was mentioned as a reason for testing. This was labeled
as ‘liver-related disease in the social environment’ and is
illustrated by the following quote:
“At this time, I have acquaintances who are dying
because of their liver. So I think the liver is very
important” (T-18).
Another reason for testing was based on the principle
of finishing what you started and was labeled as ‘gaining
a sense of accomplishment’:
“Well, I tested because I think, ‘Well, I want to
know, finish this, just do it.’” (T-17).
“There was no specific, no special reason, just to
have it done” (T-11).
Finally, some participants tested in the interest of
science or in the interest of the organization facilitating
the testing. This reason was labeled ‘feeling morally
obliged to complete participation in the study’ and is
illustrated by the following quotes:
“If everyone starts but, for whatever reason, doesn’t
finish, that doesn’t bring any good to science or
[knowledge] dissemination or anyone. So I thought,
‘Let me be the person who does do it.’” (T-12).
“I found it nice to know that people are doing this
[providing HCV testing]. It gives you the sense that
you also need to reciprocate so it won’tb eo n e -
sided” (T-17).
Reasons for not testing related to the online testing
procedures
From the interviews with participants who did not com-
ply with the test advice, we identified four reasons for
not testing related to the online testing service (see
lower right section of Figure 1). The first reason
reported was that specific features of the laboratories (e.
g .o p e n i n gh o u r s )h i n d e r e dt h e mf r o mg e t t i n gt e s t e d .
This reason was labeled as ‘inconvenient testing facilities’
and is illustrated by the following quotes:
“The laboratory which is closest to me is open until,
I believe, half past one or half past two [...] and it
didn’t get to the point that I thought, “Let’sg oo u t
of bed early to get the test.” (non-tester [NT]-15).
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test by appointment and then I thought, ‘Well, I
may be in another area someday where there is a lab
that doesn’t work with appointments and then I’ll
just walk in to have blood drawn.’ That’sj u s tm o r e
convenient.” (NT-6).
Second, the test procedures did not engage partici-
pants to commit to taking the test immediately but
rather allowed for testing until the end of the year. The
testing procedure had therefore an optional, facultative
character. This reason was labeled as ‘lack of obligatory
procedures for testing’ and is illustrated by the following
quotes:
“Because I am a diabetic, I have to get blood drawn
pretty often, and I thought ‘Well, this can wait a lit-
tle while.’ I will certainly do it in time, before
December. And that’s the deadline you determined”
(NT-9).
“I think, for these kind of things, I kind of really
need to be ordered to come. It should say, ‘Well, on
this day at that particular time, you should be there.’
Then I would probably free up time for it” (NT-7).
Third, some participants reported ‘computer/printing
problems’ as a reason for not testing:
“Iw e n tt op r i n tt h ef o r mt oh a v et h et e s ta n dm y
printer broke. It didn’t work anymore and I don’t
have a new printer yet” (NT-11).
“My computer broke down and then I actually didn’t
end up doing anything with it” (NT-12).
Finally, we found that incorrectly thinking that the
online planning tool was a real appointment planner
caused uncertainty as to whether the test could still be
taken when the planned appointment was skipped. In
this situation, we found ‘incorrectly interpreting the
online planning tool’ to be a reason for not getting
tested:
“Well, I skipped the appointment and I didn’t know
whether I could go another time so I thought, ‘Well,
then I need to visit my own GP’” (NT-5).
Reasons for not testing unrelated to the online testing
service
We identified eight reasons for not testing that were
unrelated to the online testing service (see lower left
section of Figure 1). First, despite the results of their
online risk assessment, some participants felt they were
not at risk or downplayed their reported personal risk
for HCV. This reason was labeled as a ‘downplaying per-
sonal risk’:
“Actually, I naturally assumed that when you receive
blood in the hospital, it’s fine” (NT-16).
“I got a tattoo in South Africa but, from what I can
remember about that tattoo shop, it was hygienic
and they always used new needles. At the time, I
never had the sense and today I still don’th a v et h e
sense that I got something, hepatitis C or maybe
something else that you can get from unhygienic tat-
tooing.” (NT-15)
Second, some participants perceived the likelihood of
being HCV-infected as low because they did not have
HCV-related symptoms. The ‘absence of HCV symptoms
as an indication of HCV-negative status’ is illustrated by
the following quote:
“Otherwise I would be completely yellow now. In
any event, I don’t have any symptoms” (NT-10).
Third, some participants mentioned that there was no
immediate need to test as they were not suffering from
physical distress that disrupted their daily lives. This
reason for not testing does not reflect the perception
that one is not at risk but rather it reflects a perceived
lack of immediate need to test that is rooted in the per-
ception that the potential HCV infection is not a handi-
cap to the participant’s daily functioning. The argument
‘low perceived urgency for testing due to the absence of
physical complaints’ is illustrated by the following quote:
“Id o n ’t have any physical complaints now, regard-
l e s so fw h e t h e ro rn o tIh a v ei t .T h e r e ’sn oe m e r -
gency. [...] And because now I have little, actually,
no complaints, it is not on the top of my priority
list. It is not something I really have to do.” (NT-15).
We also found that some participants perceived that
there was little to be gained from diagnosing and treat-
ing a long-term persisting infection now instead of later,
and therefore postponed testing. The ‘low perceived
urgency for HCV treatment’ is illustrated by the follow-
ing:
“It is not something that is life-threatening. It is not
like if I don’t get treated within a month, I will be
dead by next month. You know, because it is such a
long time ago” (NT-8).
Furthermore, some participants reported rejecting the
test advice in order to prevent emotional worries about
being infected. This was labeled as ‘avoiding threatening
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“I always think that you shouldn’t always take every-
thing to heart because, if you do, you’ll feel it your-
self too. I always try to be very straight in that.
When I have a headache, I don’tt h i n k ,‘Well then, I
will probably also have this and that.’ [...] It [not
seeking testing] is because of that. We shouldn’t take
everything to heart.” (T-11).
In addition, ‘fearing the negative consequences of a
positive test result’ and the corresponding uncertainty
regarding the chain of events following a positive test
result was also an impediment to testing:
“Is taking the medication hard? Are you stuck with it
for the rest of your life? What is it? What are the
risks? I don’t have a clue. And imagine that the test
result is positive. Then you think, “What am I get-
ting myself into?” (NT-6).
“It is just like [...] pretending it isn’tt h e r e[ . . . ]b u r y -
ing your head in the sand. [...] I just have to, how
can I say it, I have to get the courage to take that
step. [...] Yes, because imagine that it is not good,
you would have never taken that into account.”
(NT-9).
Some participants mentioned ‘discouraging individuals
in the social environment’ as a reason for not testing, as
illustrated by the following:
“I didn’t go and get the test yet because my husband
says, ‘Well, you don’th a v et od oi t . ’ [...] My children
also took a look at the laboratory form and ques-
tioned whether it was necessary. [...] Actually, in the
beginning, I thought I’d go to the Public Health Ser-
vice and because other people saw it [the form] and
said to me, ‘Oh, you don’t need to do it,’ that’sw h y
I haven’t done it yet.” (NT-13).
Also, ‘competing events’ were found to impede testing
for HCV, as illustrated by the following quote:
“Unexpectedly, my father had surgery so I am always
at the hospital and I haven’tb e e na b l et od oa n y -
thing for myself. So I haven’t tested yet because of
these private matters.” (NT-8).
Finally, some participants ‘thought they had already
been tested for HCV elsewhere’ and therefore did not get
tested again:
“Yes, I wanted to do the test but my GP had already
sent me for extensive blood work because, lately, I
haven’t been feeling well. Then it turned out that
my blood had been tested for almost everything and
the results showed that my blood was okay.” (NT-3)
Reasons for intention to test among noncompliant
participants
Without explicit solicitation, the majority (11/15) of the
participants who did not comply with the test advice
expressed the intention to get tested in the future. One
reason was the ‘ease of testing’:
“Actually I assume that I’m not infected. That’s what
plays a role but, because it is that easy, I think, ‘Well
let’s then do it just to be sure’” (NT-6).
Another reason is the ‘anonymity of the testing service’
as illustrated by the following quote:
“Where I live - a small village - if you got to the
local care unit where blood is drawn, you see all
sorts of people you know. If you sit there, then
you’re either pregnant or you have some scary dis-
ease. Well for me, I don’tl i k et h a t ,s oI ’dp r e f e rt o
go to Amsterdam.” (NT-5).
Both of the above-mentioned reasons for intention to
test are comparable to reasons for testing mentioned by
the compliant participants.
Participants with the intention to test also mentioned
reasons related to the benefits of testing. Again, these
were identical to those mentioned by the compliant par-
ticipants. These were ‘preventing of liver disease’: “I
think everything is okay but there is a chance that I
have it. So then maybe it is just better to know and
maybe go through nasty treatment for a while so that I
don’t have complaints later on.” (NT-15); ‘curability of
HCV’: “Well if you read that if you’re infected, it is pos-
sible to get treated, then I think, ‘Well, maybe I should
find that out’” (NT-6); ‘seeking reassurance’: “Yes, I
intend to test just to know for sure that it’sn o tt h e r e ”
(NT-13); and ‘preventing the further transmission of
HVC’: “Yes, well, I have four children so [...] I have
another responsibility too. If I were to get sick then I
could also infect my children” (NT-5).
Discussion
The purpose of this study was to gain a better under-
standing of, firstly, why some people who receive online
advice to test for HCV comply with that advice while
others do not and, secondly, the role of the online test-
ing procedures in compliance and noncompliance with
testing advice. Here, we discuss our findings in relation
to existing theory. We suggest methods and strategies to
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also other comparable projects that use online tools or
aim to encourage individuals to test for HCV.
We found that the autonomous nature of the testing
procedure (i.e. with this procedure, it is possible to
obtain information independently and to get the test
without having to discuss it with a GP) motivated indivi-
duals to go for testing. From the theoretical perspective
of the theory of planned behavior, the autonomous nat-
ure of the service increases perceived behavioral control
over the testing procedure as it removes constraining
conditions (e.g. having to discuss testing with a GP).
The autonomous nature of the service clearly illustrates
the added value of internet-based screening projects
complementary to existing prevention and screening
options. In future screening projects, the autonomous
nature of the testing procedure should to serve as the
strongest selling-point in communication about the
service.
Furthermore, we found that getting an HCV test was
also motivated by the fact that knowing one’sH C Vs t a -
tus can provide reassurance for those who test negative,
and can prevent liver disease and inhibit the further
transmission of HCV through the initiation of treatment
and precautionary measures for those who test positive.
Also, knowing that HCV is curable promotes testing.
From the perspective of the health belief model, these
reasons reflect the expected benefits of testing that can
be obtained from either a positive test result followed by
treatment and preventive measures or a negative test
result (reassurance). We suggest that screening projects
communicate not only the physical gains of testing posi-
tive but also the emotional benefits that testing negative
can potentially offer to especially individuals in low pre-
valence populations.
As expected, high perceived severity of HCV and high
perceived vulnerability to HCV motivated individuals to
seek testing. High perceived severity was based on
experiences with liver disease in the social environment,
where seeing significant others suffer from liver disease
increased the will to prevent the disease. High perceived
vulnerability was mainly based on the personal test
advice that was tailored to the individual’s risk profile.
The positive effect of tailored health information on
screening uptake has been demonstrated previously. For
example, Skinner et al. found that among groups with
low adherence to breast cancer screening (African
American and low-income women), a mammography
recommendation letter that was tailored to women’s
specific health belief model perceptions resulted in a
higher mammography adherence at follow-up compared
to those who received a nontailored version of the letter
[24]. Both perceived vulnerability and severity fit the
health belief model, in which especially high perceived
vulnerability is an important predictor of performing a
desired health behavior [17]. Among the participants in
our study, however, sometimes strong feelings of vulner-
ability were based on previously experiences or events
that do not carry any risk for acquiring HCV or on phy-
sical complaints unrelated to HCV. For these indivi-
duals, the project’s threatening information likely
created excessive worry that, in turn, motivated testing.
Although it was the project’s aim to motivate individuals
at risk for HCV to seek testing, this finding indicated
that presenting threatening information may also moti-
vate the ‘worried well’ to seek testing. We suggest that
HCV screening campaigns increase the perceived rele-
vance of testing for those at risk while also seeking to
mitigate the worried well response. This could be done
by presenting information about potential personal risk
for HCV together with information about the issues that
might cause individuals to needlessly worry about HCV
(e.g. risks related to other less severe infections).
Furthermore, we found that some individuals got
tested to gain a sense of accomplishment and a sense of
personal gratification from getting the test that could be
interpreted as an anticipated positive emotional reaction.
Others claimed to have a moral obligation to complete
their participation in the study, which appears to be a
form of altruism. Other studies have shown that altru-
ism can indeed motivate participation in research and
other projects [e.g. [25]]. Screening projects could use
the argument of anticipated gratification in persuasive
communication that seeks to enhance compliance with
test procedures (e.g. in a reminder message).
Reminder messages and the online planning tool were
indicated by some users as facilitative of testing. Remin-
d e rm e s s a g e sc a nb ed e s c r i b e db e s ta sc u e st oa c t i o n .
They help individuals to recall their initial motivation
and rationale to test. The effect of reminders has been
demonstrated previously, for example by Sequist et al
[26], who showed that colorectal cancer screening rates
were higher for patients who received mailings com-
pared with those who did not, and DeFrank et al [27],
who showed that reminders were effective in promoting
repeat mammography adherence. In our project, we
used relatively simple reminder messages that simply
stated that individuals should seek testing. The impact
of these reminders could likely be improved by includ-
ing messages that play into the established reasons for
testing (e.g. the benefits of testing or the anticipated
gratification of finishing the testing procedure).
The online planning tool that was offered to indivi-
duals after their online risk assessment supported indivi-
duals to set their testing goal and to plan each step
toward that goal. This module assisted in closing the
gap between intention and behavior and its effect has
previously been demonstrated [28]. However, in our
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they mistook the online planning tool to be a real
appointment planner and, once the planned appoint-
ment was missed, they felt uncomfortable making a new
appointment. Alternatively, they thought that they could
only test at their initially chosen location and time. We
suggest that future online planning tools include a
clearer explanation of its self-regulating nature in order
to prevent the incorrect perception that the planning
tool is a real appointment planner. It would also be
advantageous to inform those who miss their planned
test date that it is possible to get the test at another
moment in time. In addition, online planning tools
could incorporate email or SMS reminder messages
that, for example, a day prior to the planned appoint-
ment, send a reminder message in which the personal
goal (i.e. getting tested at a particular date, location, and
time) is reiterated.
With respect to the reported reasons for not using the
online HCV testing service, we found that the lack of
obligatory procedures for testing and inconvenient test-
ing facilities impeded testing. Although these aspects
reflect the autonomous nature of the testing service,
which did motivate most individuals to seek testing,
some found these very same features to be barriers to
their use of the service. Individuals had to plan the
HCV testing appointment themselves and the online
service did not incorporate any procedures that produce
high commitment for testing (e.g. scheduling real
appointments). Moreover, the online testing procedure
unintentionally offered a cue for procrastination as it
explicitly indicated a lenient deadline for testing (i.e. a
maximum of 12 months). We suggest that online
screening projects in the future provide individuals with
a clearly defined and relatively tight deadline for testing.
We recommend a period of one month as the evalua-
tion study of the HCV internet project (data not pub-
lished) showed that most individuals were tested within
two weeks.
Furthermore, we found that low perceived urgency for
testing and treatment impeded testing for HCV. From
the perspective of the health belief model, this reason
reflects low perceived severity of HCV infection which
can lead to procrastination in testing. Although it is true
that, in most cases, HCV is not an acute life-threatening
disease that demands immediate treatment, individuals
cannot precisely know the degree to which their (poten-
tial) infection has progressed. We thus suggest that
future HCV screening projects emphasize this and seek
to deter the notion that HCV treatment can be easily
p o s t p o n e d .T h i sc o u l db ed o n eb yo u t l i n i n gb o t ht h e
negative consequences of postponing an HCV test and
the benefits of immediate testing and subsequent
treatment.
Additional reasons for noncompliance with HCV test
advice were that no symptoms were present and that the
risk was downplayed. These reflect low perceived vulner-
ability of HCV infection. The absence of symptoms as an
indication that no infection has occurred might be based
on a false belief that all HCV infections are accompanied
by physical symptoms. Interestingly, the information pro-
vided by the testing service did indicate that the majority
of HCV infections are asymptomatic. The fact that indivi-
duals mentioned these reasons for not testing despite the
provision of appropriate information and personalized
advice to seek testing may reflect unrealistic optimism,
which is an optimistic bias regarding personal vulnerabil-
ity to a health threat ["It won’t happen to me"; [29]].
With this in mind, we suggest the use of scenario-based
risk information that addresses doubts about personal
risks and the consequences of downplaying of risk. For
example, future efforts to promote compliance with test
advice could use the story of a HCV-infected peer who
was diagnosed late because he did not experience any
symptoms and thought that his chance of having
acquired HCV was small.
Although low perceived severity and vulnerability
(representing low perceived threat) can lead to procras-
tination or noncompliance with testing advice, we
should be careful with respect to increasing perceived
threat as we found that some individuals showed testing
avoidance because of a high perceived threat. For these
individuals, avoidance of threatening information and
fear of the consequences of a possible positive test result
impeded testing. As such, the advice to seek testing may
have resulted in a fear control reaction as described by
the extended parallel process model. According to this
model, high perceived threat in combination with low
perceived efficacy for testing can lead to maladaptive
responses such as denial of the message and message
avoidance. Therefore, screening projects should not only
seek to address personal risk and increase the perceived
health threat of HCV; they should also endeavor to
increase individuals’ perceived response and self efficacy
for managing a possible infection. In our project, we
informed individuals about the blood testing procedure
but we did not specifically mention the face-to-face
post-test counseling session with a trained professional
that always follows a positive test result. We, therefore,
recommend that screening projects provide more detail
on the procedures that follow a positive test result.
Online screening projects could also incorporate oppor-
tunities for an immediate online post-test counseling
session (e.g. via webcam) in addition to face-to-face
counseling. Furthermore, they could include an online
module that teaches individuals the necessary skills to
overcome their fear of a positive test result by, for
example, arranging support from family members.
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direct social environment discouraged them from testing
for HCV. According to the theory of planned behavior,
a strong negative subjective norm (i.e. others’ beliefs
regarding testing plus the motivation to comply with the
beliefs of others) can influence testing behavior. In order
to overcome social pressure not to test, screening pro-
jects can offer skill-building tools that help individuals
to negotiate or withstand discouragement from their
environment. Scenarios that offer counterarguments
against a discouraging partner or demonstrate how to
surpass social pressure and maintain the original testing
intention would be beneficial in this regard.
Some participants reported a malfunctioning compu-
ter or printer as a barrier to testing. In our project, indi-
viduals could have their laboratory form emailed to
them or they could download it onto their computer
but we did not actively offer individuals a solution to
printing problems. This technical problem could be
overcome in future screening projects by offering to
s e n dt h el a b o r a t o r yf o r mb yp o s to rb yh a v i n gt h e
laboratory forms emailed to mobile phones or to the
laboratories directly.
Finally, competing events impeded testing. Most of the
reported competing events were very serious (e.g. hospi-
talization of a family member). Consequently, the low
prioritization of HCV testing by these participants
seems reasonable. Given this finding, we suggest that
future HCV screening projects incorporate a multiple
reminder system in which individuals are reminded of
testing not only a couple of days after their risk assess-
ment, as in our project, but also a couple of weeks later.
Although our study focused on reasons for compliance
and noncompliance with advice to test for HCV, some
noncompliant participants mentioned that they still
intended to test. These participants provided similar rea-
sons for testing as the advice-compliant participants.
This suggests that the reasons for testing and the rea-
sons for not testing may have played a role in both tes-
ters’ and non-testers’ decision-making. It would be
interesting to further investigate what discriminates
individuals who eventually test from those who do not.
It could be that testers encountered the impeding fac-
tors to a lower extent or that they overcame these fac-
tors better than non-testers. Quantitative studies in the
future could provide further insight regarding the pre-
sence and strength of the various reasons among both
groups and their relation to testing.
T oo u rk n o w l e d g e ,t h i si st h ef i r s ts t u d yt oe x p l o r e
reasons for compliance and noncompliance with an
HCV test advice in the general population. Previous stu-
dies have been conducted among drug users [30-32]. In
these studies, some of the reasons for testing or not
testing for HCV were similar to those identified by our
study. For example, these studies also found that a moti-
vating factor is that the test enables avoidance of the GP
and an impeding factor is low perceived risk of being
infected. However, the drug users in these studies rarely
mentioned reasons for testing related to health benefits.
They also mentioned many dissimilar reasons for non-
compliance such as fear of needles, perceived lack of
confidentiality regarding test results, and fear of discri-
mination and stigmatization. This seems to suggest that
HCV testing projects targeting active drug users should
have a different focus (e.g. focus on issues relevant to
drug users’ lifestyles and competing problems) than
HCV testing projects targeting the general population.
Our study has a number of limitations. First, the parti-
cipants were individuals who had responded to a HCV
campaign, completed the online risk assessment ques-
tionnaire, and left their email address. Individuals who
did not respond to the campaign or who left the website
before completing the risk assessment questionnaire
were not invited to participate. This could generate a
selection bias whereby our study sample includes rela-
tively more individuals who were informed and com-
mitted to the service. Also, women and individuals of
Dutch origin dominated the study sample and not all
risk groups for HCV were represented (e.g. individuals
born to an HCV-positive mother). Future research
should focus on the reasons for (non-)participation of
these groups.
Conclusions
This study has shown that our online screening cam-
paign motivated individuals to test because the testing
service is autonomous, because tailored risk information
is provided, because a reminder message service is in
place, and because there is an online planning tool.
Furthermore, our study elicited a number of feasible
intervention targets to improve the uptake of HCV test-
ing in general. We suggest that HCV screening projects
include a deadline for testing and anticipate the
responses of individuals with low perceived risk for
HCV by, for example, raising awareness of personal risk
and outlining the consequences of not testing. Also,
projects could communicate the emotional benefits of
testing negative in addition to the physical gains of test-
ing positive. Furthermore, projects could provide addi-
tional insight regarding the procedures that follow a
positive test result. We propose that organizing an effec-
tive low threshold HCV testing procedure for the gen-
eral population could not have been successful without
the internet. Given its tailoring capabilities, flexibility,
and the relatively low costs, the internet is a promising
tool not only for arranging HCV testing but also for
motivating individuals to get tested by providing them
with advice based on a personal risk profile. In addition,
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Page 11 of 12we believe that the anonymous character of the internet
and subsequent testing procedures are especially helpful
for addressing stigmatized diseases like HCV.
Acknowledgements
The authors would like to all participants for their participation in this study
and Sarah Stutterheim for editing this manuscript. This study was funded in
full by the Netherlands Organization for Health Research and Development
(ZonMW; grant no. 6120.0016).
Author details
1Cluster Infectious Diseases, Department of Research, Public Health Service
of Amsterdam, Amsterdam, the Netherlands.
2Center for Infection and
Immunology Amsterdam (CINIMA), Academic Medical Center (University of
Amsterdam), Amsterdam, the Netherlands.
3Department of Work and Social
Psychology, Faculty of Psychology and Neuroscience, Maastricht University,
Maastricht, the Netherlands.
Authors’ contributions
FRZ coordinated the study, carried out the interviews, participated in the
data analyses and interpretation, and drafted the manuscript. TRLJH
participated in the data analyses and interpretation, and contributed to the
drafting of the manuscript. ATU carried out the interviews and participated
in the data analyses, and contributed to the drafting of the manuscript. MP
contributed to the study design, the interpretation of the results, and
drafting of the manuscript. GK contributed to the interpretation of the
results and drafting of the manuscript. UD conceived and supervised the
study and analyses, and led the writing. All authors read and approved the
final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 30 July 2010 Accepted: 10 May 2011 Published: 10 May 2011
References
1. Perz JF, Farrington LA, Pecoraro C, Hutin YJ, Armstrong GL: Estimated
Global Prevalence of Hepatitis C Virus Infection. 42nd Annual Meeting of
the Infectious Diseases Society of America, Boston, MA, USA. Sept 30-Oct 3,
2004 .
2. McHutchison JG: Understanding hepatitis C. Am J Manag Care 2004, 10:
S21-S29.
3. Micallef JM, Kaldor JM, Dore GJ: Spontaneous viral clearance following
acute hepatitis C infection: a systematic review of longitudinal studies. J
Viral Hepat 2006, 13:34-41.
4. Seeff LB: Natural history of chronic hepatitis C. Hepatology 2002,
36(Suppl-46).
5. Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB: Estimating the future
health burden of chronic hepatitis C and human immunodeficiency
virus infections in the United States. J Viral Hepat 2007, 14:107-115.
6. Sypsa V, Touloumi G, Papatheodoridis GV, Tassopoulos NC, Ketikoglou I,
Vafiadis I, Hatzis G, Tsantoulas D, Akriviadis E, Koutsounas S, Hatzakis A:
Future trends of HCV-related cirrhosis and hepatocellular carcinoma
under the currently available treatments. J Viral Hepat 2005, 12:543-550.
7. Grishchenko M, Grieve RD, Sweeting MJ, De AD, Thomson BJ, Ryder SD,
Irving WL: Cost-effectiveness of pegylated interferon and ribavirin for
patients with chronic hepatitis C treated in routine clinical practice. Int J
Technol Assess Health Care 2009, 25:171-180.
8. National Institutes of Health Consensus Development Conference
Statement: Management of hepatitis C. Hepatology 2002, 36:S3-20.
9. Siebert U, Sroczynski G, Rossol S, Wasem J, Ravens-Sieberer U, Kurth BM,
Manns MP, McHutchison JG, Wong JB: Cost effectiveness of peginterferon
alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial
treatment of chronic hepatitis C. Gut 2003, 52:425-432.
10. Vrolijk JM, DE Knegt RJ, Veldt BJ, Orlent H, Schalm SW: The treatment of
hepatitis C: history, presence and future. Neth J Med 2004, 62:76-82.
11. Wong JB: Hepatitis C: cost of illness and considerations for the economic
evaluation of antiviral therapies. Pharmacoeconomics 2006, 24:661-672.
12. McHutchison JG, Bacon BR: Chronic hepatitis C: an age wave of disease
burden. Am J Manag Care 2005, 11:S286-S295.
13. Takkenberg B, de BJ, Weegink C, Jansen P, Reesink H: Novel therapies in
hepatitis B and C. Curr Gastroenterol Rep 2008, 10:81-90.
14. Health Council of the Netherlands: Committee on Hepatitis C: Detection and
treatment of people with hepatitis C Rijswijk; 1997.
15. Zuure FR, Davidovich U, Coutinho RA, Kok G, Hoebe CJ, van den Hoek A,
Jansen PL, Van Leeuwen-Gilbert P, Verheuvel NC, Weegink CJ, Prins M:
Using mass media and the internet as tools to diagnose hepatitis C
infections in the general population. Am J Prev Med 2011, 40:345-352.
16. Gollwitzer PM: Implementation Intentions: Strong effects of simple plans.
American Psychologist 1999, 54:493-501.
17. Janz NK, Becker MH: The Health Belief Model: a decade later. Health Educ
Q 1984, 11:1-47.
18. Rosenstock I: The health belief model and preventive health behavior.
Health Education Monographs 1974, 2:354-386.
19. Ajzen I: The theory of planned behavior. Organizational behavior and
human decision processes 1991, 50:179-211.
20. Witte K: Putting the fear back into fear appeals: The extended parallel
process model. Communicaton Monographs 1992, 59:329-349.
21. Mikolajczak J, Hospers HJ, Kok G: Reasons for not taking an HIV-test
among untested men who have sex with men: an Internet study. AIDS
and Behavior 2006, 10:431-435.
22. Glaser BG, Strauss A: The discovery of grounded theory: Strategies for
qualitative research. Chicago, IL: Aldine; 1967.
23. Smith JA: Semi-structured interviewing and qualitative analysis. In
Rethinking Methods in Psychology. Edited by: Smith JA, Harre R, Langenhove
LV. London: Sage; 1995:9-26.
24. Skinner CS, Strecher VJ, Hospers H: Physicians’ recommendations for
mammography: do tailored messages make a difference? Am J Public
Health 1994, 84:43-49.
25. Andresen EL, Wilson KA, Castillo A, Koopman C: Patient motivation for
participating in clinical trials for depression: validation of the motivation
for clinical trials inventory-depression. International Clinical
Psychopharmacology 2010, 25:7-16.
26. Sequist TD, Zaslavsky AM, Marshall R, Fletcher RH, Ayanian JZ: Patient and
physician reminders to promote colorectal cancer screening: a
randomized controlled trial. Archives of Internal Medicine 2009,
169:364-371.
27. DeFrank JT, Rimer BK, Gierisch JM, Bowling JM, Farrell D, Skinner CS: Impact
of mailed and automated telephone reminders on receipt of repeat
mammograms: a randomized controlled trial. American Journal of
Preventive Medicine 2009, 36:459-467.
28. Gollwitzer PM, Sheeran P: Implementation Intentions and Goal
Achievement: a meta-analysis of effects and processes. Advances in
Experimental Social Psychology 2006, 38:69-119.
29. Weinstein ND: Unrealistic optimism about susceptibility to health
problems: conclusions from a community-wide sample. J Behav Med
1987, 10:481-500.
30. Khaw FM, Stobbart L, Murtagh MJ: ’I just keep thinking I haven’t got it
because I’m not yellow’: a qualitative study of the factors that influence
the uptake of Hepatitis C testing by prisoners. BMC Public Health 2007,
7:98.
31. Strauss SM, Munoz-Plaza C, Tiburcio NJ, Astone-Twerell J, Des Jarlais DC,
Gwadz M, Hagan H, Osborne A, Rosenblum A: Barriers and facilitators to
undergoing hepatitis C virus (HCV) testing through drug treatment
programs. Journal of Drug Issues 2008, 38:1161-1185.
32. Aitken CK, Kerger M, Crofts N: Peer-delivered hepatitis C testing and
counselling: a means of improving the health of injecting drug users.
Drug Alcohol Rev 2002, 21:33-37.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2458/11/293/prepub
doi:10.1186/1471-2458-11-293
Cite this article as: Zuure et al.: Reasons for compliance or
noncompliance with advice to test for hepatitis C via an internet-
mediated blood screening service: a qualitative study. BMC Public Health
2011 11:293.
Zuure et al. BMC Public Health 2011, 11:293
http://www.biomedcentral.com/1471-2458/11/293
Page 12 of 12